Story thread · 2 reports / 2 sources
Berlin’s Apheris and Ginkgo bring pharma giants together to train AI on 10,000 antibodies
tech.eu · 8h · first report
Ginkgo Datapoints and Berlin-based Apheris today announced that the Antibody Developability Consortium has kicked off with its founding members. The Consortium is a new industry collaboration designed...
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.